Skip to content

Clinical trials

Phase 1 Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Phase 1 Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20068
20076
20085
20097
20104
20124
20141
20155
20172
20186
20192
20211
20224
20232
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Unknown status8
Terminated4
Withdrawn2
Recruiting2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline25
National Institute of Mental Health (NIMH)5
Luye Pharma Group Ltd.3
Mclean Hospital2
Soterix Medical2
St Patrick's Hospital, Ireland2
University of Oxford2
China Academy of Chinese Medical Sciences1
Digestome Therapeutics1
First Affiliated Hospital of Chongqing Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder64
Major Depressive Disorder14
Anxiety Disorders13
Depressive Disorder, Treatment-Resistant7
Mental Disorders6
Mood Disorders6
Bipolar Disorder4
Psychotic Disorders2
Schizophrenia2
Stress Disorders, Post-Traumatic2

Trials

Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.